Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Spinal Nerves: Plexus II01:21

Spinal Nerves: Plexus II

The plexuses of the lower body include the lumbar, sacral, and coccygeal plexuses, which innervate the abdomen, pelvis, legs, and coccygeal region. These plexuses control the transmission of sensory information and coordinate motor functions of the lower body.
The Lumbar Plexus
The lumbar plexus is situated within the lumbar region of the back and is primarily formed by the first four lumbar spinal nerves (L1 to L4). This plexus extends its branches into several nerves, including the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparative analysis of early postoperative outcomes of autologous pericranium versus high-density polypropylene in cranial duraplasty in a tertiary care center in Central India.

Chinese neurosurgical journal·2026
Same author

Trigeminal Neurosarcoidosis as a Neurosurgical Dilemma: A Literature Review and Illustrative Case.

Neurology India·2026
Same author

Transdural Cisternotomy in the Extended Middle Fossa Approach.

Neurology India·2026
Same author

Giant planum sphenoidale meningioma: rationale for Dolenc's step in the pterional approach.

Neurosurgical focus: Video·2026
Same author

mGem: AAV, from almost a virus to an awesome vector-or is it?

mBio·2026
Same author

Total and Neutralizing Antibody Seroprevalence of Hepatotropic Adeno-Associated Virus Among Healthy and Hemophilia A or B Population from India.

Human gene therapy·2025

Related Experiment Video

Updated: Jun 7, 2026

Teratoma Generation in the Testis Capsule
05:24

Teratoma Generation in the Testis Capsule

Published on: November 7, 2011

Sacrococcygeal teratoma.

Arun Srivastava1, Awadhesh K Jaiswal, Kapil Jain

  • 1Department of Neurosurgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

Journal of Pediatric Neurosciences
|November 3, 2010
PubMed
Summary

This neuroimage case study details a Type II sacrococcygeal teratoma, outlining its clinical and radiological features, pathology, and surgical treatment for better understanding of this rare tumor.

Keywords:
Sacrococcygeal teratomaradiological featuressurgery

More Related Videos

Fate Mapping of Human Embryonic Stem Cells by Teratoma Formation
08:56

Fate Mapping of Human Embryonic Stem Cells by Teratoma Formation

Published on: August 1, 2010

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

Related Experiment Videos

Last Updated: Jun 7, 2026

Teratoma Generation in the Testis Capsule
05:24

Teratoma Generation in the Testis Capsule

Published on: November 7, 2011

Fate Mapping of Human Embryonic Stem Cells by Teratoma Formation
08:56

Fate Mapping of Human Embryonic Stem Cells by Teratoma Formation

Published on: August 1, 2010

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

Area of Science:

  • Neuroimaging
  • Pediatric Surgery
  • Oncology

Background:

  • Sacrococcygeal teratomas are congenital tumors with varying clinical presentations.
  • Type II sacrococcygeal teratoma presents a specific subtype with distinct characteristics.

Purpose of the Study:

  • To present a comprehensive clinicoradiological and pathological overview of a Type II sacrococcygeal teratoma.
  • To summarize the surgical management strategies for this condition.

Main Methods:

  • Review of a specific neuroimaging case.
  • Correlation of radiological findings with pathological features.
  • Description of the surgical approach and outcomes.

Main Results:

  • Detailed clinicoradiological findings of the Type II sacrococcygeal teratoma.
  • Pathological confirmation of the tumor type.
  • Successful surgical resection and management.

Conclusions:

  • Type II sacrococcygeal teratoma requires precise clinicoradiological assessment.
  • Multidisciplinary surgical management is crucial for optimal outcomes.
  • Understanding pathological features guides treatment decisions.